Company Novartis AG

NOVN

CH0012005267

Pharmaceuticals

Real-time Estimate Cboe Europe Other stock markets 05:47:03 2025-06-17 EDT			5-day change	1st Jan Change
95.98 ^CHF	-0.40%		-1.70%	+8.13%

06-16	NOVARTIS AG : UBS sticks Neutral	ZD
06-12	Swiss Market Index Close Little Changed; Novartis Shares Rise	MT

Business description: Novartis AG

Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales break down by therapeutic area as follows:

- oncology (29.3%);

- immunology (18.5%);

- cardiovascular, renal and metabolic diseases (17%);

- neuroscience (9.4%).

The remaining net sales (25.8%) are from contract manufacturing of pharmaceutical products.

At the end of 2024, Novartis AG had over 30 production sites worldwide.

Net sales are distributed geographically as follows: Europe (30.9%), the United States (42%), Asia/Africa/Australasia (20%), Canada and Latin America (7.1%).

Number of employees: 75,883

Sales by Activity: Novartis AG

Fiscal Period: December	2020	2021	2022	2023	2024
Innovative Medicines	40.82B	43.97B	43.37B	46.66B	51.72B
Sandoz	9.89B	9.87B	9.48B	-	-
Corporate (Including Eliminations)	-813M	-964M	-1.02B	-	-

See all business segments

Geographical breakdown of sales: Novartis AG

Fiscal Period: December	2020	2021	2022	2023	2024
United States	16.48B	16.82B	17.65B	17.96B	21.15B
Other	19.04B	20.81B	20.05B	15.87B	18.51B
China	2.57B	3.05B	3.13B	3.27B	3.89B
Germany	4.52B	4.87B	4.28B	3.37B	3.66B
France	2.44B	2.52B	2.26B	1.75B	1.79B
Switzerland	800M	873M	970M	1.31B	1.32B
Japan	2.8B	2.68B	2.2B	1.92B	-

See all geographic segments

Executive Committee: Novartis AG

Manager	Title	Age	Since
Vasant Narasimhan CEO	Chief Executive Officer	49	2018-01-31
Harry Werner Kirsch DFI	Director of Finance/CFO	60	2013-04-23
Shreeram Aradhye CTO	Chief Tech/Sci/R&D Officer	63	2022-05-15
Karen Hale CMP	Compliance Officer	57	2025-04-13
Steffen Lang COO	Chief Operating Officer	58	2022-04-03

See NOVARTIS AG governance

Composition of the Board of Directors: Novartis AG

Director	Title	Age	Since
Nancy Andrews BRD	Director/Board Member	66	2014-12-31
Liz Doherty BRD	Director/Board Member	68	2015-12-31
Ton Büchner BRD	Director/Board Member	60	2015-12-31
Frans van Houten BRD	Director/Board Member	65	2017-02-27
Patrice Bula BRD	Director/Board Member	69	2019-02-27
Bridgette Heller BRD	Director/Board Member	63	2020-02-27
Simon Moroney BRD	Director/Board Member	66	2020-02-27
Ana de Pro Gonzalo BRD	Director/Board Member	58	2022-03-03
Daniel Hochstrasser BRD	Director/Board Member	65	2022-03-03
John Young BRD	Director/Board Member	61	2023-03-06

Composition of the Board of Directors

Shareholders: Novartis AG

Name	Equities	%	Valuation
NOVARTIS AG 6.787 %	148,621,654	6.787 %	17 010 M CHF
Sandoz Family Foundation 4.1 %	89,787,150	4.1 %	10 277 M CHF
State Street Global Advisors Ltd. 0.2165 %	4,741,689	0.2165 %	543 M CHF
Sjunde AP-fonden 0.1539 %	3,370,792	0.1539 %	386 M CHF
DWS CH AG 0.0982 %	2,151,087	0.0982 %	246 M CHF

Name	Equities	%	Valuation
Dodge & Cox 0.5397 %	11,818,102	0.5397 %	1 368 M CHF
PRIMECAP Management Co. 0.4741 %	10,382,879	0.4741 %	1 202 M CHF
DFA Australia Ltd. 0.3698 %	8,097,302	0.3698 %	937 M CHF
Eaton Vance Management 0.3222 %	7,055,911	0.3222 %	817 M CHF
Fisher Asset Management LLC 0.3088 %	6,763,132	0.3088 %	783 M CHF

Name	Equities	%	Valuation
LUKB Expert Fondsleitung AG -	82,294	-	9 M CHF
Skyblue Fund Managers (Pty) Ltd. -	6,000	-	691 839 CHF
Columbia Threadneedle Asset Managers Ltd. -	972	-	112 078 CHF

List of NOVARTIS AG shareholders

Holdings: Novartis AG

Name	Equities	%	Valuation
NOVARTIS AG 6.79%	148,621,654	6.79%	17,010,399,263 $
NOVARTIS INDIA LIMITED 70.68%	17,450,680	70.68%	212,415,959 $
OCULIS HOLDING AG 3.57%	1,713,521	3.57%	33,327,983 $
ERASCA, INC. 4.35%	12,307,692	4.35%	17,230,769 $
THIRD HARMONIC BIO, INC. 5.87%	2,642,762	5.87%	13,768,790 $
MOLECULAR PARTNERS AG 4.31%	1,739,130	4.31%	6,774,050 $
PRECISION BIOSCIENCES, INC. 5.24%	413,581	5.24%	1,997,596 $

Company details: Novartis AG

Novartis AG

Lichtstrasse 35

4056, Basel

+41 61 324 11 11

http://www.novartis.com

Group companies: Novartis AG

Name	Category and Sector
Novartis Healthcare Pvt Ltd. Novartis Healthcare Pvt Ltd. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis Healthcare Pvt Ltd. is an Indian company that manufactures and markets health care and nutritional products. The company is based in Mumbai, India. The company was founded in 1997. The CEO is Sanjay Prabhakar Murdeshwar.	Pharmaceuticals: Major
Novartis Investment Ltd.
Novartis Holding AG Novartis Holding AG Financial ConglomeratesFinance Part of Novartis AG, Novartis Holding AG is a Swiss healthcare company that provides solutions to address the evolving needs of patients worldwide. The company is based in Basel, Switzerland. Novartis Holding specializes in Managed Access Programs and is committed to the discovery, development, and marketing of innovative products to improve the well-being of all Canadians. The company prides itself on its commitment to diversity and to nurturing an inclusive and inspiring environment.	Financial Conglomerates
Novartis International AG Novartis International AG Pharmaceuticals: MajorHealth Technology Novartis International AG manages the Novartis Group. It provides administrative, financial, legal, and technical services. It also offers scientific consultation to the Group. The company was founded on December 13, 1989 and is headquartered in Basel, Switzerland.	Pharmaceuticals: Major
Novartis Services, Inc. Novartis Services, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis Services, Inc. is a pharmaceutical company. The company is based in Cambridge, MA.	Pharmaceuticals: Major

See all subsidiaries

Other Pharmaceuticals

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi.($)
NOVARTIS AG	-0.40%	-1.70%	+2.53%	+21.08%	233B
ELI LILLY AND COMPANY	-1.44%	+4.90%	-8.07%	+175.63%	725B
JOHNSON & JOHNSON	-1.20%	+0.12%	+6.65%	-8.69%	373B
NOVO NORDISK A/S	-1.32%	-5.50%	-49.90%	+32.19%	344B
ABBVIE INC.	-0.12%	+0.54%	+13.21%	+38.21%	337B
ROCHE HOLDING AG	-0.02%	-2.63%	+7.01%	-13.44%	260B
ASTRAZENECA PLC	-0.31%	+0.09%	-13.24%	+10.47%	228B
MERCK & CO., INC.	-0.92%	+2.52%	-37.47%	-4.34%	203B
AMGEN INC.	+0.12%	+1.80%	-1.02%	+25.46%	159B
PFIZER, INC.	-0.57%	+4.50%	-11.37%	-49.70%	139B
Average	-0.32%	+1.70%	-9.17%	+22.69%	300.11B
Weighted average by Cap.	-0.27%	+2.28%	-8.67%	+49.35%